Start-up entrée en incubation en 2001.
Founded in 1999, PELVIPHARM is a spin-off from the University of Versailles-Saint-Quentin-en-Yvelines (France) relying on multi-disciplinary talents (medical doctor, pharmaco-economist, veterinarian, pharmacists and PhDs) who deliver both high quality academic standards and reliablecontract research services :
• Preclinical studies based on validated efficacy models including delivery of protocol development, study conduct, report, communication and peer-reviewed publication
• Guidance for selection of new chemical entities including testing with targeted assays according to potential mechanisms of action
• Identification of new properties or attributes supporting differentiation of medications within
the class or between classes
• Advice in clinical development for new therapeutic indications or enhancements to address unmet medical need or significant commercial opportunities